UAB Researchers to Study Silent Strokes
A stroke is typically caused by a clot that cuts off blood supply to the brain, and when it happens, there are usually signs, such as facial drooping and slurred speech. But silent strokes, caused by smaller clots, are unrecognizable, according to UAB neuropsychologist Ronald Lazar.
“You have the same kind of signals, but they’re so small that, in and of themselves, each one does not cause symptoms that you’re going to recognize,” Lazar says, “But over many years, we think they do cause a problem.”
He says previous studies show that silent strokes increase the likelihood of having a larger stroke and of developing dementia. But in general, Lazar says there is a lack of research about the impact of these small neurological events and ways to prevent them. In a new study funded by the National Institutes of Health, he and fellow researchers at UAB and Stanford University hope to fill in some of the gaps.
Centers for Disease Control and Prevention
Alabama has one of the highest stroke mortality rates in the country.
The study, which is part of a larger national study called ARCADIA, will enroll 500 patients who have already had a stroke, and researchers will follow them for three years. During that time, participants will take a daily dose of an anticoagulant drug, either Aspirin or Apixaban. At the beginning and end of the study, investigators will use Magnetic Resonance Imaging to look for evidence of silent strokes. They will also conduct annual interviews to monitor for cognitive decline.
Lazar says they hope to improve understanding of how silent strokes might affect cognitive function overtime and study the preventative impact of both anticoagulant drugs.
“The fundamental goal is trying to minimize the occurrence of stroke in patients who might ordinarily be at high risk,” Lazar says.
Trump administration’s embattled FDA vaccine chief is leaving for the second time
The FDA's controversial vaccine chief, Dr. Vinay Prasad, is leaving the agency. It's the second time he has abruptly departed following decisions involving the review of vaccinations and specialty drugs.
Family, former presidents and a Hall of Famer give Rev. Jesse Jackson a final sendoff
Several speakers at Jackson's funeral invoked his hallmark catchphrases: "Keep hope alive" and "I am somebody."
Bernard LaFayette, Selma voting rights organizer, dies at 85
Bernard LaFayette, who died Thursday, laid the foundations of the Selma, Alabama, campaign that culminated in the passage of the Voting Rights Act. He was a Freedom Rider and helped found the Student Nonviolent Coordinating Committee.
Oil surges to its highest price since 2023, and stocks drop after U.S. jobs report
Stocks fell Friday on worries that the economy could become stuck in a worst-case scenario of stagnating growth and high inflation. Oil prices touched their highest levels since 2023 after surging again because of the Iran war.
No lawsuits required: U.S. Customs is working on a system to refund tariffs
U.S. Customs told the trade court it aims for a streamlined process in 45 days to return importers' money without requiring individual lawsuits.
Poll: A majority of Americans opposes U.S. military action in Iran
Most Americans disapprove of President Trump's handling of Iran, and a majority sees Iran as either only a minor threat or no threat at all, an NPR/PBS News/Marist poll finds.
